In clinical settings, low levels of adropin have been found in individuals with arterial hypertension, obesity, T2DM, metabolic syndrome, coronary artery disease, atherosclerosis, stroke, acute coronary syndrome, chronic kidney disease, and all phenotypes of symptomatic HF [21,22,23,24,25,26,27]. Here, ENHO is linked to Hypertension.